Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Ltd. (India) holds 0 active US FDA Type II Drug Master Files and 2 inactive and has DMF or CEP filings on record for 1 active ingredient. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Jagsonpal Pharmaceuticals Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/jagsonpal-pharmaceuticals-ltd
Overview
Jagsonpal Pharmaceuticals Ltd. is a pharmaceutical company headquartered in Gurugram, India.
Active ingredients with DMF or CEP filings
Substances for which Jagsonpal Pharmaceuticals Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Jagsonpal Pharmaceuticals Ltd. holds 0 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- D-OXYPHENEInactive2006-07-27
- TRIMETHOPRIMInactive1985-04-10
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2025-02-05
FDA Warning Letter (drug product)
Is this Jagsonpal Pharmaceuticals Ltd.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.